Lactobacillus crispatus LV5
- Reduced Chlamydia trachomatis Infectivity
- Reduced Sore Throat Severity
- Reduced Candida albicans Colony-Forming Units
- Reduced Preterm Births
- Reduced Cytotoxicity
- Enhanced Antimicrobial Resistance
- Improved Symptoms of Bacterial Vaginosis
- Absence of Adverse Effects
- Reduced Interleukin-1β Levels
- Reduced Recurrence of Bacterial Vaginosis
Most-studied combinations with Lactobacillus crispatus LV5
most supplement research is combination researchAlso studied with:Lactobacillus crispatus VPro 31 (9)